Compounds > 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid
Page last updated: 2024-10-21

3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid and HIV Coinfection

3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid has been researched along with HIV Coinfection in 1 studies

3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid: structure given in first source; NMDA receptor antagonist

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wang, P1
Barks, JD1
Silverstein, FS1

Other Studies

1 other study available for 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid and HIV Coinfection

ArticleYear
Tat, a human immunodeficiency virus-1-derived protein, augments excitotoxic hippocampal injury in neonatal rats.
    Neuroscience, 1999, Volume: 88, Issue:2

    Topics: Animals; Animals, Newborn; Apoptosis; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagoni

1999